Injection Pen Is Becoming Advance with Increasing Technological Developments in Medical Device Industry

 

Injection pens are essential devices for the treatment of many chronic conditions. Using an Injection Pen correctly is critical to achieving positive outcomes. A recent study found that over 90% of first-time users were successful in injecting a controlled substance. However, a quarter of these injections were unsuccessful due to errors with the needle and the pen. Injection pens are usually used for the administration of insulin. The needles in an Injection Pen are inserted directly into the skin, rather than into a vein or muscle. However, the needles should never be reused. The pens can also be used to administer other drugs, such as vitamins or supplements. There are many types of Injection Pens on the market.

The development of an Injection Pen should be driven by the need for accurate drug delivery. The prevalence of diabetes mellitus is growing and is considered a global health emergency. The disease is prevalent among aged adults and poses a significant risk of infection. Disposable auto-injectors have improved usability. These devices have undergone several improvements since the first ones were introduced to the market. Redesigned needle covers and feedback mechanisms have helped to ensure proper usage and safety. Users can also select a needle that has the right length and lubrication. The Injection Pen Market can be used by a wide range of individuals, even by individuals who are not trained to administer injections.

Another advantage of these pens is their safety features. Some have built-in safety features, including an anti-spill mechanism, so the patient will not have to worry about accidental needle sticks or repeated injections. For example, a safety pen needle has a protective outer cover and an inner safety shield that retracts during the injection. This safety mechanism helps the patient avoid accidental needle sticks and allows the healthcare provider to check the type of needle used by the patient. In November 2020, Medtronic plc launched InPen with real-time Guardian Connect CGM data, which is the first FDA-approved smart insulin pen.

Watch the video Injection Pen:https://lumen5.com/user/poonam-165/injection-pen-market-7hwky/